Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Arndt

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1987
Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regionsJ P Portanova, R E Arndt, E M Tan, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
High-level production of a humanized immunoRNase fusion protein from stably transfected myeloma cellsJürgen Krauss, Evelyn Exner, Athanasios Mavratzas, et al.
Current Pharmaceutical Design|August 20, 2009
Ribonucleases and immunoRNases as anticancer drugsS M Rybak, M A E Arndt, T Schirrmann, et al.
Dermatology (Basel, Switzerland)|September 6, 2000
Fulminating multi-organ failure in a young woman caused by rapidly progressing melanoma metastasesP Kaskel, M Orth, E Arndt, et al.
Family Medicine|January 1, 1997
Collegial networking and faculty vitalityS E Woods, A Reid, J E Arndt, et al.
Expert Opinion on Biological Therapy|December 10, 2008
Targeted therapeutic RNases (ImmunoRNases)Thomas Schirrmann, Jürgen Krauss, Michaela A E Arndt, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 28, 2001
[Can follow-up controls improve the accuracy of MR mammography? A retrospective analysis of MR mammography follow-up studies]A Betsch, E Arndt, W Stern, et al.
Family Medicine|March 1, 1997
Outcomes of three part-time faculty development fellowship programsW A Anderson, F T Stritter, W K Mygdal, et al.
British Journal of Haematology|February 24, 2005
Targeting malignant B-cell lymphoma with a humanized anti-CD22 scFv-angiogenin immunoenzymeJürgen Krauss, Michaela A E Arndt, Bang K Vu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
A dimeric angiogenin immunofusion protein mediates selective toxicity toward CD22+ tumor cellsMichaela A E Arndt, Jürgen Krauss, Bang K Vu, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1987
Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regionsJ P Portanova, R E Arndt, E M Tan, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
High-level production of a humanized immunoRNase fusion protein from stably transfected myeloma cellsJürgen Krauss, Evelyn Exner, Athanasios Mavratzas, et al.
Current Pharmaceutical Design|August 20, 2009
Ribonucleases and immunoRNases as anticancer drugsS M Rybak, M A E Arndt, T Schirrmann, et al.
Dermatology (Basel, Switzerland)|September 6, 2000
Fulminating multi-organ failure in a young woman caused by rapidly progressing melanoma metastasesP Kaskel, M Orth, E Arndt, et al.
Family Medicine|January 1, 1997
Collegial networking and faculty vitalityS E Woods, A Reid, J E Arndt, et al.
Expert Opinion on Biological Therapy|December 10, 2008
Targeted therapeutic RNases (ImmunoRNases)Thomas Schirrmann, Jürgen Krauss, Michaela A E Arndt, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 28, 2001
[Can follow-up controls improve the accuracy of MR mammography? A retrospective analysis of MR mammography follow-up studies]A Betsch, E Arndt, W Stern, et al.
Family Medicine|March 1, 1997
Outcomes of three part-time faculty development fellowship programsW A Anderson, F T Stritter, W K Mygdal, et al.
British Journal of Haematology|February 24, 2005
Targeting malignant B-cell lymphoma with a humanized anti-CD22 scFv-angiogenin immunoenzymeJürgen Krauss, Michaela A E Arndt, Bang K Vu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
A dimeric angiogenin immunofusion protein mediates selective toxicity toward CD22+ tumor cellsMichaela A E Arndt, Jürgen Krauss, Bang K Vu, et al.
Pageof 7